The tentative approval for ANDA 218862 was posted to the Drugs@FDA site.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMRX:
- Amneal Pharmaceuticals backs prior FY24 EPS view 57c-63c, consensus 61c
- Amneal Pharmaceuticals Maintains Transparency with SEC Filing
- Amneal Pharmaceuticals director Patel sells 62,590 class A shares
- Appeals court sides with Amneal over Teva in inhaler patent fight
- Amneal resubmits DHE autoinjector NDA, gets FDA approval for exenatide